Medicus Pharma Ltd.
Ownership
Ownership Structure
Who owns Medicus Pharma Ltd. (MDCX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.4% of the shares are freely tradable; institutional investors hold 4.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Interchange Capital Partners, LLC | 2.51 | 1,586,871 | -4.5 | 06/30/2026 |
| Sterling Investment Advisors Ltd | 0.16 | 100,000 | +0.0 | 06/30/2026 |
| Virtu Financial LLC | 0.12 | 74,045 | +0.0 | 03/31/2026 |
| Commonwealth Equity Services, LLC | 0.08 | 52,643 | +9.3 | 06/30/2026 |
| Bryn Mawr Trust Company | 0.08 | 51,244 | +0.0 | 03/31/2026 |
| May Hill Capital, LLC | 0.08 | 50,622 | +0.0 | 06/30/2026 |
| UBS Group AG | 0.06 | 40,441 | +205.7 | 03/31/2026 |
| BlackRock Inc | 0.06 | 37,294 | +8.7 | 03/31/2026 |
| Citadel Advisors Llc | 0.04 | 25,102 | +40.8 | 06/30/2026 |
| Stratos Wealth Partners, LTD | 0.03 | 20,950 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Bokhari Raza | Chief Executive Officer | 2,941,176 | 500,882 $ | Sep 4, 2026 | direct |
| Bonner Carolyn F. | President and CFO | 1,489,493 | 253,661 $ | Sep 4, 2026 | direct |
| Mehmud Faisal | Chief Medical Officer | 1,470,588 | 250,441 $ | Sep 4, 2026 | direct |
| Smith Andrew Alasdair | Chief Operating Officer | 735,458 | 125,248 $ | Sep 4, 2026 | direct |
| Brennan Edward J. | Chief Scientific Officer | 674,735 | 114,907 $ | Sep 4, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Smith Andrew Alasdair | Chief Operating Officer | Other | 735,294 | 0.1705 | 125,368 |
| Sep 4, 2026 | Mehmud Faisal | Chief Medical Officer | Other | 1,470,588 | 0.1705 | 250,735 |
| Sep 4, 2026 | Brennan Edward J. | Chief Scientific Officer | Other | 588,235 | 0.1705 | 100,294 |
| Sep 4, 2026 | Bonner Carolyn F. | President and CFO | Other | 1,470,588 | 0.1705 | 250,735 |
| Sep 4, 2026 | Bokhari Raza | Chief Executive Officer | Other | 2,941,176 | 0.1705 | 501,471 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.